Current position:Home >Product >
		
		
	
N-[3-(1H-indol-2-yl)phenyl]-1-[(1-methylpyrazol-4-yl)methyl]piperidine-3-carboxamide
N-[3-(1H-indol-2-yl)phenyl]-1-[(1-methylpyrazol-4-yl)methyl]piperidine-3-carboxamide
		
  | 
      
	   
		
		   | 
      
Canonical SMILES:
CN1C=C(C=N1)CN2CCCC(C2)C(=O)NC3=CC=CC(=C3)C4=CC5=CC=CC=C5N4
Isomeric SMILES
CN1C=C(C=N1)CN2CCCC(C2)C(=O)NC3=CC=CC(=C3)C4=CC5=CC=CC=C5N4
InChI
InChI=1S/C25H27N5O/c1-29-15-18(14-26-29)16-30-11-5-8-21(17-30)25(31)27-22-9-4-7-19(12-22)24-13-20-6-2-3-10-23(20)28-24/h2-4,6-7,9-10,12-15,21,28H,5,8,11,16-17H2,1H3,(H,27,31)
      
		
	   Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
 - 2,5-bis(chloranyl)benzene-1,4-diol
 - 2,5-bis(chloranyl)phenol
 - 2-oxidanylidenehexanedioic acid
 - 2-oxidanylidene-3-sulfanyl-propanoic acid
 - 3-oxidanylbenzaldehyde
 - 3-azanylpropanal
 - 2-azanyl-3-oxidanyl-benzoic acid
 - 3-(3-hydroxyphenyl)propanoic acid
 - 3-oxidanylidenehexanedioic acid
 - N-(3-cyclopentylpropyl)-4-[1-(3-methoxypropanoyl)piperidin-4-yl]oxy-N-methyl-benzamide
 - N-[2-[1-[(1-ethylimidazol-2-yl)methyl]piperidin-4-yl]pyrazol-3-yl]-3-phenyl-propanamide
 - N-[2-[1-[[4-[bis(fluoranyl)methoxy]phenyl]methyl]piperidin-4-yl]pyrazol-3-yl]cyclopentanecarboxamide
 - N-[2-[1-[(5-chloranyl-2-oxidanyl-phenyl)methyl]piperidin-4-yl]pyrazol-3-yl]cyclopropanecarboxamide
 - N-[2-[(4-methoxyphenyl)amino]-2-oxidanylidene-ethyl]-N-methyl-5,5-bis(oxidanylidene)-8,9,10,11-tetrahydro-7H-azepino[2,1-c][1,2,4]benzothiadiazine-3-carboxamide
 - 5-[(4-chloranyl-3,5-dimethyl-phenoxy)methyl]-N-cyclobutyl-1,2-oxazole-3-carboxamide
 - 1-[2-(4-chlorophenyl)ethyl]-5-(4-oxidanylpiperidin-1-yl)carbonyl-piperidin-2-one
 - N-methyl-3-(4-oxidanylidene-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)-N-[2-oxidanylidene-2-[[2-(trifluoromethyl)phenyl]amino]ethyl]propanamide
 - [1-[(2-methoxy-5-nitro-phenyl)amino]-1-oxidanylidene-propan-2-yl] cyclopentanecarboxylate
 - N-methyl-5-[(6-methylpyridin-3-yl)oxymethyl]-N-(2-pyridin-2-ylethyl)-1,2-oxazole-3-carboxamide
 

               
       